J Cancer 2018; 9(23):4355-4362. doi:10.7150/jca.26902

Research Paper

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis

Linghui Zhou1,2,*, Cong Dai1,2,*, Tian Tian2,*, Meng Wang2, Shuai Lin2, Yujiao Deng2, Peng Xu2, Qian Hao2, Ying Wu2, Tielin Yang3, Wenge Zhu4✉, Zhijun Dai1,2✉

1. Department of Breast Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China;
2. Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;
3. School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China;
4. Department of Biochemistry and Molecular Medicine, The George Washington University Medical School, Washington, DC, USA.
*LH Z, C D and T T contributed equally to this work.


Background: Lysosome-associated protein transmembrane-4β-35(LAPTM4B-35) has been observed overexpressed in multiple malignant tumors. However, the prognostic value of LAPTM4B-35 remains controversial. Therefore, we conducted a meta-analysis to evaluate the prognostic value of LAPTM4B-35 in human cancers.

Methods: The relevant publications were obtained by systematically searching the PubMed, Web of Science, Embase, Wanfang, and China National Knowledge Infrastructure (CNKI) databases. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for the prognosis value of LAPTM4B-35 for cancer patient.

Results: Our result suggest that LAPTM4B-35 overexpression is significantly associated with poor overall survival (OS) (HR = 2.49, 95% CI = 1.87-3.32, p < 0.001), disease-free survival (DFS) (HR = 2.43, 95% CI = 1.35-4.35, p = 0.003), and progression-free survival (PFS) (HR = 4.12, 95% CI = 2.30-7.37, p < 0.001). Moreover, subgroup analysis revealed significant association with poor OS in lung (HR = 2.05, 95% CI = 1.37-3.06, p < 0.001), gastric carcinoma (HR = 1.88, 95% CI = 1.01-3.50, p < 0.047) and ovarian cancer (HR = 4.94, 95% CI = 1.44-16.94, p = 0.011).

Conclusion: LAPTM4B-35 may be a novel predictive biomarker and a potential target for treatment.

Keywords: LAPTM4B-35, cancer, prognosis, meta-analysis

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Zhou L, Dai C, Tian T, Wang M, Lin S, Deng Y, Xu P, Hao Q, Wu Y, Yang T, Zhu W, Dai Z. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis. J Cancer 2018; 9(23):4355-4362. doi:10.7150/jca.26902. Available from http://www.jcancer.org/v09p4355.htm